Although the widespread epidemic of Zika virus (ZIKV) and its neurological complications are well-known there are still no approved drugs available to treat this arboviral disease or vaccine to prevent the infection. Flavonoids from Pterogyne nitens have already demonstrated anti-flavivirus activity, although their target is unknown. In this study, we virtually screened an in-house database of 150 natural and semi-synthetic compounds against ZIKV NS2B-NS3 protease (NS2B-NS3p) using docking-based virtual screening, as part of the OpenZika project. As a result, we prioritized three flavonoids from P. nitens, quercetin, rutin and pedalitin, for experimental evaluation. We also used machine learning models, built with Assay Central® software, for predicting the activity and toxicity of these flavonoids. Biophysical and enzymatic assays generally agreed with the in silico predictions, confirming that the flavonoids inhibited ZIKV protease. The most promising hit, pedalitin, inhibited ZIKV NS2B-NS3p with an IC of 5 μM. In cell-based assays, pedalitin displayed significant activity at 250 and 500 µM, with slight toxicity in Vero cells. The results presented here demonstrate the potential of pedalitin as a candidate for hit-to-lead (H2L) optimization studies towards the discovery of antiviral drug candidates to treat ZIKV infections.Copyright © 2021 Elsevier Inc. All rights reserved.
About The Expert
Caroline Sprengel Lima
Melina Mottin
Leticia Ribeiro de Assis
Nathalya Cristina de Moraes Roso Mesquita
Bruna Katiele de Paula Sousa
Lais Durco Coimbra
Karina Bispo-Dos- Santos
Kimberley M Zorn
Rafael V C Guido
Sean Ekins
Rafael Elias Marques
José Luiz Proença-Modena
Glaucius Oliva
Carolina Horta Andrade
Luis Octavio Regasini
References
PubMed
Create Post
Twitter/X Preview
Logout